The Proliferative Phase: Estrogen-Driven Endometrial Regeneration

Menstrual Cycle Phase 2: Proliferative (Follicular) Phase

Timing: ~Days 5–14 of a 28-day cycle (variable).

Trigger: Rising estradiol from developing ovarian follicles.

Endometrial Changes

  • Thickness: Grows from ~1–2 mm (post-menses) to 8–12 mm.
  • Structure: Glands elongate, stroma becomes vascularized and edematous.
  • Molecular: ERα/ERβ upregulation, progesterone receptor induction (priming for secretory phase).
  • Cervical mucus: Becomes clear, stretchy, alkaline (spinnbarkeit) – sperm-friendly.

Ovarian Correlation

Parallels follicular phase: FSH → follicular recruitment → dominant follicle selection → estradiol surge → LH surge → ovulation (~day 14).

Clinical Relevance

  • Ultrasound: Trilaminar endometrium (≥7 mm) predicts implantation potential.
  • Thin endometrium (<7 mm): May impair implantation; causes: Asherman’s, low estrogen, Clomid, vascular issues.
  • Hyperplasia risk: Unopposed estrogen (anovulation, PCOS, estrogen therapy without progestin).

Key Hormones

  • Estradiol: Primary driver.
  • FSH/LH: Gonadotropins.
  • Inhibin B, AMH: Follicular status markers.

This phase prepares the "soil" for potential embryo implantation. If fertilization occurs, the secretory phase (progesterone-dominated) follows.

Infertility - Related Articles